Clinical Trial Update: Gastroesophageal Reflux Treatment in Scleroderma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating treatment for gastroesophageal reflux disease in patients with scleroderma/systemic sclerosis has completed with results posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Systemic Sclerosis

Snippet

Sponsor: Khon Kaen University | Conditions: Gastroesophageal Reflux Disease, Systemic Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2017-03-27